Degradation of RXRs influences sensitivity of rat osteosarcoma cells to the antiproliferative effects of calcitriol

Molecular Endocrinology

Volumn 16, Issue 5, 2002, Pages 961-976

  Prüfer, Kirsten ^a   Schröder, Claudia ^a   Hegyi, Krisztina ^a   Barsony, Julia ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALCITRIOL; GREEN FLUORESCENT PROTEIN; LACTACYSTIN; PROTEIN P21; RETINOID X RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HORMONE RESISTANCE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; REPORTER GENE; TRANSACTIVATION; WESTERN BLOTTING;

ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CALCITRIOL; CELL DIVISION; CYSTEINE ENDOPEPTIDASES; DRUG RESISTANCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MULTIENZYME COMPLEXES; OSTEOSARCOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; RETINOID X RECEPTORS; RETINOIDS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036256723     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.16.5.961     Document Type: Article

References (55)

1. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
2. Emerging new therapies for cutaneous T-cell lymphoma
3. A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer
4. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)
5. Vitamin D and its relevance to cancer
6. Vitamin D receptors in breast cancer cells
7. 3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation
8. Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1α,25-dihydroxycholecalciferol receptors
9. 3 and thyroid hormone in three osteosarcoma cell lines
10. 3
11. A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo
12. Retinoid resistance in leukemic cells
13. 3
14. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast
15. Skin abnormalities generated by temporally controlled RXRα mutations in mouse epidermis
16. 3, and retinoid signaling
17. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor γ and retinoid X receptor α in human keratinocytes
18. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR
19. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
20. 3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin
21. Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance
22. Abnormally high expression of proteasomes in human leukemic cells
23. Proteasome inhibitors: A novel class of potent and effective antitumor agents
24. 3
25. Growth inhibitory effects of 1α,25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31
26. 1-S phase-controlling machinery
27. 3 and its analogue, EB1089, in human breast cancer cells
28. Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors α and β
29. Heterodimerization is mainly responsible for the dominant negative activity of amino-terminally truncated rat androgen receptor forms
30. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions
31. Molecular perspectives on selective estrogen receptor modulators (SERMs): Progress in understanding their tissue-specific agonist and antagonist actions
32. Stable transfection of U937 cells with sense or antisense RXR-α cDNA suggests a role for RXR-α in the control of monoblastic differentiation induced by retinoic acid and vitamin D
33. 3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells
34. 3 are differently modified by 9-cis-retinoic acid
35. Signaling pathways for vitamin D-induced differentiation: Implications for therapy of proliferative and neoplastic diseases
36. 3 receptor-mediating cell cycle arrest and differentiation
37. 3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor
38. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid
39. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines
40. Thyroid hormone, vitamin D and retinoid receptor expression and signalling in primary cultures of rat osteoblastic and immortalised osteosarcoma cells
41. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex
42. Inhibition of ligand induced promoter occupancy in vivo by a dominant negative RXR
43. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins
44. Limited degradation of retinoid X receptor by calpain
45. Cleavage of RXRα by a lysosomal enzyme, cathepsin L-type protease
46. Ligand-induced alteration of the protease sensitivity of retinoid X receptor α
47. Mechanism of action of superactive vitamin D analogs through regulated receptor degradation
48. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors α and γ through the ubiquitin-proteasome pathway
49. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells
50. Hormone-dependent translocation of vitamin D receptors is linked to transactivation
51. Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors
52. 3 dependency of vitamin D receptor-retinoid X receptor-vitamin D-responsive element complex formation
53. Coincidence of the promoter and capped 5′ terminus of RNA from the adenovirus 2 major late transcription unit
54. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors
55. 3 receptor in mammalian cells using recombinant adenovirus vectors